Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes.

Wimazal, F; Sperr, W R; Kundi, M; Meidlinger, P; Fonatsch, C; Jordan, J H; Thalhammer-Scherrer, R; Schwarzinger, I; Geissler, K; Lechner, K; Valent, P

Wimazal, F; Sperr, W R; Kundi, M; Meidlinger, P; Fonatsch, C; Jordan, J H; Thalhammer-Scherrer, R; Schwarzinger, I; Geissler, K; Lechner, K; Valent, P.

Affiliation

Wimazal F; Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, Währinger Gürtel 18-20, A-1090, Vienna, Austria

Leuk Res ; 25(4): 287-94, 2001 Apr.

Article in En | MEDLINE | ID: mdl-11248325

Subject(s)

L-Lactate Dehydrogenase/blood; Myelodysplastic Syndromes/enzymology; Actuarial Analysis; Acute Disease; Adult; Aged; Aged, 80 and over; Analysis of Variance; Cell Transformation, Neoplastic/metabolism; Female; Humans; Leukemia, Myeloid/diagnosis; Leukemia, Myeloid/enzymology; Male; Middle Aged; Myelodysplastic Syndromes/classification; Myelodysplastic Syndromes/diagnosis; Prognosis; Risk Factors; Survival Rate

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / L-Lactate Dehydrogenase Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leuk Res Year: 2001 Type: Article Affiliation country: Austria

Search on Google

XML

PubMed Links